COMMONWEALTH EQUITY SERVICES, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$535
+5.5%
4,410
-0.4%
0.00%0.0%
Q2 2023$507
-23.9%
4,426
-8.5%
0.00%0.0%
Q1 2023$666
+5.9%
4,836
-0.5%
0.00%
-50.0%
Q4 2022$629
-99.9%
4,861
+5.4%
0.00%
+100.0%
Q3 2022$509,000
+47.5%
4,613
+0.2%
0.00%0.0%
Q2 2022$345,000
-4.2%
4,606
-0.1%
0.00%0.0%
Q1 2022$360,000
-14.1%
4,609
-1.1%
0.00%0.0%
Q4 2021$419,000
-4.8%
4,662
-2.1%
0.00%0.0%
Q3 2021$440,000
+29.8%
4,763
+9.0%
0.00%0.0%
Q2 2021$339,000
-0.3%
4,371
-4.4%
0.00%0.0%
Q1 2021$340,000
-77.2%
4,571
-47.8%
0.00%
-75.0%
Q4 2020$1,492,000
+18.0%
8,755
-2.8%
0.00%0.0%
Q3 2020$1,264,000
-7.4%
9,006
+5.8%
0.00%
-20.0%
Q2 2020$1,365,000
+71.9%
8,515
+4.8%
0.01%
+25.0%
Q1 2020$794,000
-45.1%
8,124
-27.6%
0.00%
-33.3%
Q4 2019$1,447,000
+75.6%
11,220
+2.5%
0.01%
+50.0%
Q3 2019$824,000
-42.6%
10,951
+15.8%
0.00%
-33.3%
Q2 2019$1,436,000
+31.5%
9,454
+3.2%
0.01%
+20.0%
Q1 2019$1,092,000
+11.2%
9,164
+1.8%
0.01%0.0%
Q4 2018$982,000
-34.0%
9,006
-2.4%
0.01%
-28.6%
Q3 2018$1,489,000
+25.3%
9,223
+2.6%
0.01%
+16.7%
Q2 2018$1,188,000
+98.3%
8,989
+11.0%
0.01%
+100.0%
Q1 2018$599,000
+18.4%
8,097
-10.9%
0.00%0.0%
Q4 2017$506,0009,0910.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders